B(C6F5)3-Catalyzed Formal (n+3) (n = 5,6) Cycloaddition of Bicyclo[1.1.0]butanes to Medium Bicyclo[n.1.1]alkanes

15 March 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Herein, a B(C6F5)3-catalyzed formal (n+3) (n = 5,6) cycloaddition of bicyclo[1.1.0]butanes (BCBs) with imidazolidines/hexahydropyrimidines is described. The reaction provides a modular, atom-economical and efficient strategy to two libraries of synthetically challenging medium-bridged rings, 2,5-diazabicyclo[5.1.1]nonanes and 2,6-diazabicyclo[6.1.1]decanes, in moderate to excellent yields. This reaction also features simple operation, mild reaction conditions and broad substrate scope. A scale-up experiment and various synthetic transformations of products further highlight the synthetic utility. Control experiments support that the reaction mechanism involves a nucleophilic addition of imidazolidines/hexahydropyrimidines to B(C6F5)3-activated BCBs, succeeded by an intramolecular cyclization. As we know, this methodology represents the first high order (n+3) (n > 3) cycloaddition of BCBs to saturated bicyclo[n.1.1]alkanes. We anticipate that this report will promote the exploration of BCB-based high order cycloaddition chemistry to access diverse challenging medium-bridged rings.

Keywords

bicyclo[1.1.0]butane
imidazolidine/hexahydropyrimidine
B(C6F5)3 catalysis
Bicyclo[n.1.1]alkanes
high order cycloaddition

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Experimental procedures along with characterizing data, copies of NMR spectra, and X-ray crystallographic data were available in the Supporting Information (PDF)
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.